GPT and metabolic dysfunction-associated steatotic liver disease: In the present study, when the rats started diet supplement at 8 weeks old, compared to the reference range [38] (Table S3), they had significant higher levels of blood GLU, BUN, TBIL, ALT, ALP and AMY, which may represent a sign of mild diabetes (higher GLU), pancreatic (higher AMY) and nonalcoholic fatty liver disease (higher ALT, ALP, TBIL and BUN).